|
US20090297602A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Devane John G |
Modified Release Loxoprofen Compositions
|
|
JP4613275B2
(ja)
*
|
1998-11-02 |
2011-01-12 |
エラン ファーマ インターナショナル，リミティド |
多粒子改質放出組成物
|
|
ES2213404T3
(es)
*
|
1998-12-17 |
2004-08-16 |
Alza Corporation |
Transformacion de capsulas de gelatina rellenas de liquido en sistemas de liberacion controlada mediante multiples revestimientos.
|
|
AU2084801A
(en)
*
|
1999-12-09 |
2001-06-18 |
Alza Corporation |
Antiviral medication
|
|
AR026148A1
(es)
*
|
2000-01-21 |
2003-01-29 |
Osmotica Argentina S A |
Dispositivo osmotico con pasaje preformado que aumenta de tamano
|
|
KR20040018394A
(ko)
*
|
2001-07-04 |
2004-03-03 |
썬 파마슈티컬 인더스트리스 리미티드 |
위 정체 제어되는 약물 전달 계
|
|
US6720002B2
(en)
*
|
2001-07-20 |
2004-04-13 |
R.P. Scherer Technologies, Inc. |
Antihistamine formulations for soft capsule dosage forms
|
|
CA2471081A1
(en)
*
|
2001-12-19 |
2003-07-03 |
Alza Corporation |
Formulation & dosage form for the controlled delivery of therapeutic agents
|
|
NZ533060A
(en)
*
|
2001-12-19 |
2006-03-31 |
Alza Corp |
Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
|
|
WO2004034791A1
(en)
*
|
2002-10-21 |
2004-04-29 |
Givaudan Sa |
Pesticidal compositions
|
|
KR101046903B1
(ko)
*
|
2002-06-26 |
2011-07-06 |
인타르시아 세라퓨틱스 인코포레이티드 |
삼투성 약물 전달 시스템을 위한, 최소로 튀는 용적효율성 피스톤
|
|
TW200414900A
(hu)
*
|
2002-06-28 |
2004-08-16 |
|
|
|
JP2005533084A
(ja)
*
|
2002-06-28 |
2005-11-04 |
アルザ・コーポレーシヨン |
液体の有効成分の製剤を含んでなりかつ膨張可能な浸透圧組成物によりその放出を制御する経口の投薬形態
|
|
ATE373472T1
(de)
*
|
2002-07-29 |
2007-10-15 |
Alza Corp |
Verfahren und dosierformen für die kontrollierte abgabe von paliperidon
|
|
US20050232995A1
(en)
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
|
WO2004041255A1
(en)
*
|
2002-10-31 |
2004-05-21 |
Alza Corporation |
Dosage form providing ascending release of liquid formulation
|
|
CN1728982A
(zh)
*
|
2002-10-31 |
2006-02-01 |
阿尔扎公司 |
可增加疏水性药物生物利用度的药物制剂
|
|
US7988993B2
(en)
|
2002-12-09 |
2011-08-02 |
Andrx Pharmaceuticals, Inc. |
Oral controlled release dosage form
|
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
|
US20040131672A1
(en)
*
|
2003-01-07 |
2004-07-08 |
Nilobon Podhipleux |
Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
|
|
US7037521B2
(en)
*
|
2003-03-28 |
2006-05-02 |
Bausch & Lomb Incorporated |
Using a laser for cutting a hole in a capsule for controlled drug delivery
|
|
JP5628467B2
(ja)
|
2003-06-26 |
2014-11-19 |
シヴィダ・ユーエス・インコーポレイテッドＰｓｉｖｉｄａ Ｕｓ， Ｉｎｃ． |
生体分解性徐放性ドラッグデリバリーシステム
|
|
CN1842321B
(zh)
*
|
2003-06-26 |
2012-07-04 |
控制递送系统有限公司 |
生物蚀解性缓释递药系统
|
|
TWI377958B
(en)
|
2003-06-26 |
2012-12-01 |
Control Delivery Sys Inc |
In-situ gelling drug delivery system
|
|
US20050003070A1
(en)
*
|
2003-07-03 |
2005-01-06 |
Foster David V. |
Shelf stable vitamin C in oatmeal products
|
|
KR100767271B1
(ko)
*
|
2003-07-11 |
2007-10-17 |
에프. 호프만-라 로슈 아게 |
사퀴나비르 메실레이트 경구 투여 형태
|
|
PL2279729T3
(pl)
*
|
2003-07-17 |
2017-02-28 |
Banner Life Sciences Llc |
Preparaty o kontrolowanym uwalnianiu
|
|
NZ527142A
(en)
*
|
2003-07-23 |
2006-03-31 |
Douglas Pharmaceuticals Ltd |
A stable suspension formulation
|
|
AU2004261277A1
(en)
*
|
2003-07-31 |
2005-02-10 |
Alza Corporation |
Permeation-Resistant osmotic engine and dosage form for controlled release of a liquid active agent formulation
|
|
EP1575565B1
(en)
*
|
2003-08-08 |
2010-01-06 |
Biovail Laboratories International Srl |
Modified-release tablet of bupropion hydrochloride
|
|
KR20060095765A
(ko)
*
|
2003-09-26 |
2006-09-01 |
알자 코포레이션 |
알프라졸람의 제어 송달용 삼투성 제형
|
|
CN101005829A
(zh)
*
|
2003-10-21 |
2007-07-25 |
艾克塔维斯集团公司 |
喹硫平制剂
|
|
KR20060120193A
(ko)
*
|
2003-11-14 |
2006-11-24 |
알자 코포레이션 |
액체 제형내 토피라메이트의 제어된 방출
|
|
US20050181049A1
(en)
*
|
2003-11-19 |
2005-08-18 |
Dong Liang C. |
Composition and method for enhancing bioavailability
|
|
US20050181050A1
(en)
*
|
2004-01-28 |
2005-08-18 |
Collegium Pharmaceutical, Inc. |
Dosage forms using drug-loaded ion exchange resins
|
|
EP1593376A1
(en)
*
|
2004-05-04 |
2005-11-09 |
Warner-Lambert Company LLC |
Improved pullulan capsules
|
|
US7619007B2
(en)
|
2004-11-23 |
2009-11-17 |
Adamas Pharmaceuticals, Inc. |
Method and composition for administering an NMDA receptor antagonist to a subject
|
|
EP1827385B1
(en)
|
2004-11-23 |
2013-03-27 |
Adamas Pharmaceuticals, Inc. |
Pharmaceutical composition comprising memantine in an extended dosage release form for use in the treatment of dementias
|
|
EP2623099A1
(en)
|
2004-11-24 |
2013-08-07 |
Neuromolecular Pharmaceuticals, Inc |
Composition and method for treating neurological disease
|
|
WO2006063078A2
(en)
*
|
2004-12-08 |
2006-06-15 |
Elan Corporation, Plc |
Topiramate pharmaceuticals composition
|
|
EP1827377B1
(en)
*
|
2004-12-14 |
2008-03-19 |
Novartis AG |
In-situ forming implant for animals
|
|
EP1858492B1
(en)
*
|
2005-01-27 |
2008-11-12 |
ALZA Corporation |
Oral osmotic dosage form having a high flux membrane
|
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
|
WO2006121560A2
(en)
|
2005-04-06 |
2006-11-16 |
Adamas Pharmaceuticals, Inc. |
Methods and compositions for treatment of cns disorders
|
|
US20060257484A1
(en)
*
|
2005-04-19 |
2006-11-16 |
Hwang Stephen S |
Combination of tramadol and substances that comprise gabapentin
|
|
US20100136106A1
(en)
*
|
2005-06-08 |
2010-06-03 |
Gary Liversidge |
Modified Release Famciclovir Compositions
|
|
AR055099A1
(es)
*
|
2005-07-28 |
2007-08-08 |
Alza Corp |
Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
|
|
US20070082046A1
(en)
*
|
2005-10-11 |
2007-04-12 |
Banner Pharmacaps, Inc. |
Enteric valproic acid
|
|
EP3047847A1
(en)
*
|
2005-10-12 |
2016-07-27 |
OPKO Renal, LLC |
Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency
|
|
CA2675901A1
(en)
*
|
2005-10-13 |
2007-04-19 |
Duke University |
Compositions for the treatment and prevention of heart disease and methods of using same
|
|
US20070087055A1
(en)
*
|
2005-10-14 |
2007-04-19 |
David Jan |
Directly compressible extended release alprazolam formulation
|
|
US20070092559A1
(en)
*
|
2005-10-24 |
2007-04-26 |
Jinghua Yuan |
Liquid dosage forms having enteric properties of delayed and then sustained release
|
|
PL116330U1
(en)
*
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
|
DK1993559T3
(en)
*
|
2006-02-03 |
2016-10-03 |
Opko Renal Llc |
Treatment of vitamin D deficiency and MALFUNCTION with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
|
|
US20070196487A1
(en)
*
|
2006-02-16 |
2007-08-23 |
Geerke Johan H |
Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
|
|
CA2651855C
(en)
|
2006-05-30 |
2011-08-02 |
Intarcia Therapeutics, Inc. |
Two-piece, internal-channel osmotic delivery system flow modulator
|
|
US20070281008A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Lin Shun Y |
Personal lubricant compositions and kits for providing personal lubrication
|
|
ES2670029T3
(es)
|
2006-06-21 |
2018-05-29 |
Opko Ireland Global Holdings, Ltd. |
Terapia usando agente de repleción de la vitamina D y agente de reemplazo de la hormona de la vitamina D
|
|
DE102006032427A1
(de)
*
|
2006-07-13 |
2008-01-17 |
Neuraxpharm Arzneimittel Gmbh U. Co. Kg |
Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung
|
|
DE102006032426A1
(de)
*
|
2006-07-13 |
2008-01-17 |
Neuraxpharm Arzneimittel Gmbh U. Co. Kg |
Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung
|
|
US20080038334A1
(en)
*
|
2006-08-08 |
2008-02-14 |
John Zazula |
Method for producing and a system for cooling a hot-filled softgel capsule
|
|
ES2422864T3
(es)
|
2006-08-09 |
2013-09-16 |
Intarcia Therapeutics, Inc |
Sistemas de liberación osmótica y unidades de pistón
|
|
EP2106732B1
(en)
*
|
2007-01-30 |
2016-03-16 |
Olympus Corporation |
Device for checking for lumen passage and method of producing device for checking for lumen passage
|
|
US8524749B2
(en)
*
|
2007-02-09 |
2013-09-03 |
Alza Corporation |
Controlled release compositions of tizanidine
|
|
PT2157967E
(pt)
|
2007-04-23 |
2013-04-03 |
Intarcia Therapeutics Inc |
Formulações de suspensões de péptidos insulinotrópicos e suas utilizações
|
|
KR101495578B1
(ko)
|
2007-04-25 |
2015-02-25 |
사이토크로마 인코포레이티드 |
비타민 ｄ 부족 및 결핍의 치료 방법
|
|
EP3225243A1
(en)
|
2007-04-25 |
2017-10-04 |
Opko Renal, LLC |
Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
|
|
DK2481400T3
(da)
|
2007-04-25 |
2014-09-29 |
Opko Ip Holdings Ii Inc |
Orale præparater med kontrolleret frigivelse omfattende en vitamin D-forbindelse og en voksagtig bærer
|
|
CA2684778C
(en)
|
2007-04-25 |
2017-09-05 |
Cytochroma Inc. |
Methods and compounds for vitamin d therapy
|
|
UA97971C2
(ru)
*
|
2007-06-08 |
2012-04-10 |
Берингер Ингельхайм Интернациональ Гмбх |
Препарат невирапина пролонгированного высвобождения
|
|
AU2008286914B2
(en)
*
|
2007-08-13 |
2014-10-02 |
Ohemo Life Sciences Inc. |
Abuse resistant drugs, method of use and method of making
|
|
EP2209455A1
(en)
*
|
2007-10-15 |
2010-07-28 |
Glaxo Group Limited |
Paneled capsule shells for release of pharmaceutical compositions
|
|
WO2009050193A1
(en)
*
|
2007-10-15 |
2009-04-23 |
Glaxo Group Limited |
Method and apparatus for manufacturing filled linkers
|
|
CN101827571A
(zh)
*
|
2007-10-15 |
2010-09-08 |
葛兰素集团有限公司 |
用于释放一种或多种药物成分的多部分剂型的连接件及所得剂型
|
|
US20090110724A1
(en)
*
|
2007-10-31 |
2009-04-30 |
Everett Laboratories, Inc. |
Compositions and methods for treatment of pain
|
|
EP3320921B1
(en)
*
|
2007-11-05 |
2022-01-05 |
Ala Wai Pharma, Inc. |
Formulations for enhanced bioavailability of orally administered polar agents
|
|
US9138430B2
(en)
*
|
2007-12-27 |
2015-09-22 |
Mylan Specialty L.P. |
Formulation and method for the release of paroxetine in the large intestine
|
|
AU2008343787B2
(en)
|
2007-12-28 |
2014-01-30 |
Impax Laboratories, Llc |
Controlled release formulations of levodopa and uses thereof
|
|
EP2240155B1
(en)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
|
ES2954932T3
(es)
|
2008-04-02 |
2023-11-27 |
Eirgen Pharma Ltd |
Métodos, composiciones, usos y kits útiles para la deficiencia de vitamina D y trastornos relacionados
|
|
US20090311335A1
(en)
*
|
2008-06-12 |
2009-12-17 |
Scott Jenkins |
Combination of a triptan and an nsaid
|
|
CN105581984A
(zh)
*
|
2009-04-09 |
2016-05-18 |
阿尔科米斯制药爱尔兰有限公司 |
药物递送组合物
|
|
PT2442791T
(pt)
|
2009-06-16 |
2020-02-06 |
Pfizer |
Formas farmacêuticas de apixaban
|
|
US20130029970A1
(en)
|
2009-07-10 |
2013-01-31 |
Ironwood Pharmaceuticals, Inc |
CB Receptor Agonists
|
|
CN101596174B
(zh)
*
|
2009-07-13 |
2011-04-06 |
北京航洋胶囊技术有限公司 |
一种软胶囊及其制备方法
|
|
KR101823699B1
(ko)
|
2009-09-28 |
2018-01-30 |
인타르시아 세라퓨틱스 인코포레이티드 |
실질 항정상태 약물 전달의 신속 확립 및/또는 종결
|
|
US20120277180A1
(en)
|
2009-09-30 |
2012-11-01 |
Vitapath Genetics, Inc |
Cofactors and Methods for Use for Individuals
|
|
US20130129827A1
(en)
|
2009-10-16 |
2013-05-23 |
Ranbaxy Laboratories Limited |
Extended release pharmaceutical compositions of paliperidone and processes of preparation thereof
|
|
BR112012013487A2
(pt)
|
2009-12-02 |
2017-10-03 |
Adamas Pharmaceuticals Inc |
Composições de amantadina e métodos de uso
|
|
AR079492A1
(es)
|
2009-12-23 |
2012-02-01 |
Ironwood Pharmaceuticals Inc |
Moduladores de crth2
|
|
WO2011100324A1
(en)
|
2010-02-09 |
2011-08-18 |
Ironwood Pharmaceuticals Inc. |
Cannabinoid receptor agonists
|
|
US20130178453A1
(en)
|
2010-02-09 |
2013-07-11 |
Ironwood Pharmaceuticals, Inc. |
Cannabinoid Agonists
|
|
US20130178475A1
(en)
|
2010-03-17 |
2013-07-11 |
Ironwood Pharmaceuticals, Inc. |
sGC STIMULATORS
|
|
US8486013B2
(en)
*
|
2010-03-18 |
2013-07-16 |
Biotronik Ag |
Balloon catheter having coating
|
|
CN105796530A
(zh)
|
2010-03-29 |
2016-07-27 |
赛特克罗公司 |
用于降低甲状旁腺水平的方法和组合物
|
|
MX339805B
(es)
|
2010-04-22 |
2016-06-10 |
Intra Cellular Therapies Inc |
Compuestos organicos.
|
|
WO2011161666A2
(en)
*
|
2010-06-21 |
2011-12-29 |
White Innovation Ltd. |
Enclosed liquid capsules
|
|
JP5860459B2
(ja)
|
2010-06-30 |
2016-02-16 |
アイアンウッド ファーマシューティカルズ インコーポレイテッド |
ｓＧＣ刺激薬
|
|
US20130216552A1
(en)
|
2010-07-12 |
2013-08-22 |
Ironwood Pharmaceuticals, Inc. |
Crth2 modulators
|
|
WO2012009134A1
(en)
|
2010-07-12 |
2012-01-19 |
Ironwood Pharmaceuticals, Inc. |
Crth2 modulators
|
|
CN103402515B
(zh)
|
2010-11-09 |
2017-05-17 |
铁木医药有限公司 |
sGC刺激剂
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
KR20140054066A
(ko)
|
2011-07-15 |
2014-05-08 |
뉴서트 사이언시스, 인크. |
대사 경로 조절을 위한 조성물 및 방법
|
|
TWI615155B
(zh)
*
|
2011-11-01 |
2018-02-21 |
拜耳股份有限公司 |
滲透活性的陰道遞送系統
|
|
WO2013101830A1
(en)
|
2011-12-27 |
2013-07-04 |
Ironwood Pharmaceuticals, Inc. |
2 - benzyl, 3 - (pyrimidin- 2 -yl) substituted pyrazoles useful as sgc stimulators
|
|
CN103211797B
(zh)
*
|
2012-01-18 |
2017-06-06 |
北京天衡医院管理有限公司 |
盐酸维拉帕米膜控缓释微丸胶囊
|
|
US9198454B2
(en)
|
2012-03-08 |
2015-12-01 |
Nusirt Sciences, Inc. |
Compositions, methods, and kits for regulating energy metabolism
|
|
WO2013155422A1
(en)
|
2012-04-12 |
2013-10-17 |
Ironwood Pharmaceuticals, Inc. |
Methods of treating alopecia and acne
|
|
CA2870303A1
(en)
|
2012-04-14 |
2013-10-17 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
JP6273261B2
(ja)
*
|
2012-04-30 |
2018-01-31 |
ダウ アグロサイエンシィズ エルエルシー |
有害生物防除剤組成物送達ビヒクル
|
|
US11312878B2
(en)
*
|
2012-07-23 |
2022-04-26 |
Lotte Fine Chemical Co., Ltd. |
Aqueous composition for preparing hard capsule, preparation method therefor, hard capsule, and method for recycling hard capsule scraps
|
|
WO2014047111A1
(en)
|
2012-09-18 |
2014-03-27 |
Ironwood Pharmaceuticals, Inc. |
Sgc stimulators
|
|
EP2897953B8
(en)
|
2012-09-19 |
2019-06-26 |
Cyclerion Therapeutics, Inc. |
Sgc stimulators
|
|
WO2014078459A1
(en)
|
2012-11-13 |
2014-05-22 |
Nusirt Sciences, Inc. |
Compositions and methods for increasing energy metabolism
|
|
WO2014113404A1
(en)
|
2013-01-15 |
2014-07-24 |
Nusirt Sciences, Inc. |
Treating pulmonary conditions
|
|
GB201303781D0
(en)
|
2013-03-04 |
2013-04-17 |
Gauthier Pierre Pascal |
Oral timer device and method of using same
|
|
CA2902879C
(en)
|
2013-03-15 |
2023-09-26 |
Nusirt Sciences, Inc. |
Leucine and nicotinic acid reduces lipid levels
|
|
EP2976082A4
(en)
|
2013-03-15 |
2016-05-11 |
Inspirion Delivery Technologies Llc |
MISS-INFANT COMPOSITIONS AND METHODS OF USE
|
|
KR101847947B1
(ko)
|
2013-03-15 |
2018-05-28 |
옵코 아이피 홀딩스 Ⅱ 인코포레이티드 |
안정화되고 변형된 비타민 ｄ 방출 제형
|
|
US9708322B2
(en)
|
2013-03-15 |
2017-07-18 |
Intra-Cellular Therapies, Inc. |
Substituted pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines for inhibiting serotonin reuptake transporter activity
|
|
RS59981B1
(sr)
|
2013-03-15 |
2020-03-31 |
Cyclerion Therapeutics Inc |
Sgc stimulatori
|
|
CN103315973B
(zh)
*
|
2013-05-24 |
2014-05-07 |
杭州和正医药有限公司 |
喹硫平的渗透泵型控释制剂
|
|
US10154971B2
(en)
|
2013-06-17 |
2018-12-18 |
Adamas Pharma, Llc |
Methods of administering amantadine
|
|
EP2839853A1
(de)
*
|
2013-08-23 |
2015-02-25 |
LTS LOHMANN Therapie-Systeme AG |
Transdermales therapeutisches System mit Druckerzeugungsvorrichtung
|
|
EP3054929B1
(en)
|
2013-10-07 |
2020-08-05 |
Impax Laboratories, LLC |
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
|
|
US10987313B2
(en)
|
2013-10-07 |
2021-04-27 |
Impax Laboratories, Llc |
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
|
|
WO2015085004A1
(en)
|
2013-12-03 |
2015-06-11 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
|
JP2016540017A
(ja)
|
2013-12-11 |
2016-12-22 |
アイアンウッド ファーマシューティカルズ インコーポレイテッド |
ｓＧＣ刺激物質
|
|
KR102199596B1
(ko)
*
|
2013-12-31 |
2021-01-07 |
롯데정밀화학 주식회사 |
경질 캡슐용 수성 조성물 및 이를 사용하여 제조된 경질 캡슐
|
|
KR102161001B1
(ko)
*
|
2013-12-31 |
2020-09-29 |
롯데정밀화학 주식회사 |
경질 캡슐용 수성 조성물 및 이를 사용하여 제조된 경질 캡슐
|
|
MX2016011063A
(es)
|
2014-02-27 |
2016-11-30 |
Nusirt Sciences Inc |
Composiciones y metodos para la reduccion o prevencion de esteatosis hepatica.
|
|
CN106456638A
(zh)
|
2014-04-04 |
2017-02-22 |
细胞内治疗公司 |
有机化合物
|
|
PL3125893T3
(pl)
|
2014-04-04 |
2024-02-12 |
Intra-Cellular Therapies, Inc. |
Deuterowane gamma-karboliny w fuzji z heterocyklami jako antagoniści receptorów 5-HT2A
|
|
WO2015191554A1
(en)
|
2014-06-09 |
2015-12-17 |
Intra-Cellular Therapies, Inc. |
Compounds and methods of use to treat schizophrenia
|
|
US10220047B2
(en)
|
2014-08-07 |
2019-03-05 |
Opko Ireland Global Holdings, Ltd. |
Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
|
|
US10729685B2
(en)
|
2014-09-15 |
2020-08-04 |
Ohemo Life Sciences Inc. |
Orally administrable compositions and methods of deterring abuse by intranasal administration
|
|
WO2016044445A2
(en)
|
2014-09-17 |
2016-03-24 |
Ironwood Pharmaceuticals, Inc. |
sGC STIMULATORS
|
|
AU2015317824A1
(en)
|
2014-09-17 |
2017-03-23 |
Cyclerion Therapeutics, Inc. |
Pyrazole derivatives as sGC stimulators
|
|
CN107406421A
(zh)
|
2014-09-17 |
2017-11-28 |
铁木医药有限公司 |
sGC刺激物
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
US9808608B2
(en)
|
2014-11-16 |
2017-11-07 |
International Business Machines Corporation |
Helical coil delivery device for active agent
|
|
US10925639B2
(en)
|
2015-06-03 |
2021-02-23 |
Intarcia Therapeutics, Inc. |
Implant placement and removal systems
|
|
US20170119680A1
(en)
|
2015-10-30 |
2017-05-04 |
R.P. Scherer Technologies, Llc |
Extended release film-coated capsules
|
|
AU2016381366A1
(en)
|
2015-12-30 |
2018-06-28 |
Adamas Pharmaceuticals, Inc. |
Methods and compositions for the treatment of seizure-related disorders
|
|
PL3407888T3
(pl)
|
2016-01-26 |
2021-08-30 |
Intra-Cellular Therapies, Inc. |
Związki pirydopirolochinoksaliny, ich kompozycje i zastosowania
|
|
RU2733975C2
(ru)
|
2016-03-25 |
2020-10-08 |
Интра-Селлулар Терапиз, Инк. |
Органические соединения
|
|
IL290855B2
(en)
|
2016-03-28 |
2024-06-01 |
Eirgen Pharma Ltd |
Treatment methods using vitamin D
|
|
EP3436083A4
(en)
|
2016-03-28 |
2019-11-27 |
Intra-Cellular Therapies, Inc. |
NEW COMPOSITIONS AND METHODS
|
|
KR102574993B1
(ko)
|
2016-05-16 |
2023-09-06 |
인타르시아 세라퓨틱스 인코포레이티드 |
글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
|
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
|
WO2018009566A1
(en)
*
|
2016-07-06 |
2018-01-11 |
Durect Corporation |
Oral dosage form with drug composition, barrier layer and drug layer
|
|
KR20230124760A
(ko)
|
2016-09-02 |
2023-08-25 |
사이클리온 테라퓨틱스, 인크. |
융합된 비시클릭 sGC 자극제
|
|
CN110072518B
(zh)
|
2016-10-12 |
2021-10-26 |
细胞内治疗公司 |
无定形固体分散体
|
|
AU2017356887B2
(en)
|
2016-11-08 |
2022-06-30 |
Cyclerion Therapeutics, Inc. |
sGC stimulators
|
|
EP3538096B1
(en)
|
2016-11-08 |
2024-02-28 |
Tisento Therapeutics Inc. |
Treatment of cns diseases with sgc stimulators
|
|
US10906906B2
(en)
|
2016-12-29 |
2021-02-02 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
US10961245B2
(en)
|
2016-12-29 |
2021-03-30 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders
|
|
KR20190104039A
(ko)
|
2017-01-03 |
2019-09-05 |
인타르시아 세라퓨틱스 인코포레이티드 |
Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법
|
|
CN110430879B
(zh)
|
2017-03-24 |
2023-04-21 |
细胞内治疗公司 |
新组合物和方法
|
|
WO2018200885A1
(en)
|
2017-04-26 |
2018-11-01 |
Neurocentria, Inc. |
Magnesium compositions and methods of use
|
|
WO2019023062A1
(en)
|
2017-07-26 |
2019-01-31 |
Intra-Cellular Therapies, Inc. |
ORGANIC COMPOUNDS
|
|
CN111093664B
(zh)
|
2017-07-26 |
2023-06-02 |
细胞内治疗公司 |
有机化合物
|
|
MX2020009668A
(es)
|
2018-03-16 |
2021-01-08 |
Intra Cellular Therapies Inc |
Métodos novedosos.
|
|
US20210009592A1
(en)
|
2018-03-23 |
2021-01-14 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
CA3094949A1
(en)
|
2018-03-23 |
2019-09-26 |
Intra-Cellular Therapies, Inc. |
Deuterated heterocycle fused gamma-carbolines
|
|
US20210031201A1
(en)
*
|
2018-04-15 |
2021-02-04 |
Optofluidic Bioassay, Llc |
Differential pressure assisted drainage system
|
|
CA3102948A1
(en)
|
2018-06-08 |
2019-12-12 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
|
WO2019241278A1
(en)
|
2018-06-11 |
2019-12-19 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines synthesis
|
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|
|
KR20210052471A
(ko)
|
2018-08-31 |
2021-05-10 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
신규한 방법
|
|
MX2021002321A
(es)
|
2018-08-31 |
2021-04-28 |
Intra Cellular Therapies Inc |
Nuevos metodos.
|
|
CN114072150A
(zh)
|
2019-07-07 |
2022-02-18 |
细胞内治疗公司 |
新方法
|
|
US10940088B1
(en)
*
|
2020-01-09 |
2021-03-09 |
King Saud University |
Method of preparing low dose pharmaceutical formulations
|
|
CN112641751B
(zh)
*
|
2020-09-25 |
2022-06-21 |
广州玖洲胶囊生物科技有限公司 |
一种羟丙甲基纤维素和卡拉胶的填充空心充液胶囊
|
|
US11986449B2
(en)
|
2020-12-22 |
2024-05-21 |
Amneal Pharmaceuticals Llc |
Levodopa dosing regimen
|
|
WO2024145659A1
(en)
|
2022-12-30 |
2024-07-04 |
Intra-Cellular Therapies, Inc. |
Heterocycle fused gamma-carbolines acting on the serotonine 5-ht2a receptor
|